期刊文献+

基于“药效-成分分析”的银屑灵优化方2号方抗银屑病配伍规律探讨 被引量:8

Discussion on the synergy rule of PSORI-CM02 in treating psoriasis based on pharmacodynamic-component analysis
原文传递
导出
摘要 目的:探讨银屑灵优化方2号方(PSORI-CM02)治疗银屑病的配伍规律。方法:将PSORI-CM02拆分为清热解毒方、凉血活血方和清热解毒+凉血活血方,采用心得安豚鼠银屑病模型,考察总方及拆方对该模型的病理状态影响并进行Baker评分;利用HPLC测定总方及拆方中绿原酸、芍药苷、落新妇苷、黄杞苷、迷迭香酸、白藜芦醇在水提液中的含量变化。结果:PSORI-CM02及拆方均能够显著降低银屑病豚鼠的Baker评分(P<0.01),PSORI-CM02药效显著优于凉血活血组(P<0.05)和清热解毒组(P<0.01),其余组间无显著差异;落新妇苷和黄杞苷含量与处方药效存在正相关关系。结论:配伍通过增强处方活性成分溶出增强药效。 Objective:To investigate the possible synergy rule of PSORI-CM02 in the treating psoriasis.Methods:PSORI-CM02 was divided into clearing heat and detoxification decoction,cooling blood and invigorating circulation decoction,and the combination of above decoction.Psoriasis-like model in guinea pigs were applied as the pharmacological study model,and pathological morphology assessment was examined with baker score.The content of chlorogenic acid,paeoniflorin,astilbin,engeletin,rosmarinic acid and resveratrol in different dismantlement of PSORI-CM02 were determined by high performance liquid chromatography.Results:Both dismantling prescription and PSORI-CM02 decreased the baker scores in psoriasis-like model of guinea pigs(P<0.01).The effect of PSORI-CM02 was superior to the cooling blood and invigorating circulation group(P<0.05)and the clearing heat and detoxification group(P<0.01),and there was no significant difference in other medicated groups.There is a positive correlation between the content of astilbin and engeletin and the efficacy of the prescription.Conclusion:By enhancing the dissolution of prescription active ingredients,the synergy enhanced the effect of medicine.
作者 刘丽娟 赵瑞芝 卢传坚 LIU Li-juan;ZHAO Rui-zhi;LU Chuan-jian(The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510006,China;Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome,Guangzhou 510120,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2020年第8期4171-4174,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 广东省自然科学基金项目(No.S2013030011515) 广东省中医药科学技术研究专项(No.YN2016MJ08)。
关键词 银屑灵优化方2号方 配伍 土茯苓 落新妇苷 黄杞苷 银屑病 PSORI-CM02 Synergy Rhizoma Smilacis Glabrae Astilbin Engeletin Psoriasis
  • 相关文献

参考文献5

二级参考文献56

共引文献56

同被引文献129

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部